Hypogonadism affects 2-4 million men in the United States, but because of the nonspecific nature of the symptoms, most men do not complain, and the condition remains underdiagnosed. Furthermore, prevailing concepts of ‘maleness’ and sexuality, and lack of awareness among primary care physicians, contribute to disregarding the importance of male hypogonadism, even though it is associated with a reduced quality of life. As a result, many male patients with hypogonadism are untreated. Physicians may also encounter problems with testosterone assays because various proprietary agents are employed, and reference ranges in standard reference texts may not correspond to values quoted by clinical laboratories. Many questions pertaining to the treatment of hypogonadism continue to remain unanswered. This webcast is an interactive, case-based, educational activity that will increase practitioner skills and confidence in the evaluation and management of male patients with hypogonadism.
Expiration for this program was extended from November 11, 2011 to July 31, 2012. Latest Review Date: July 31, 2011.
At the conclusion of this activity, participants should be better able to:
- Discuss the prevalence of male hypogonadism;
- Order appropriate lab tests to make a diagnosis and understand the full scope of the problem;
- Identify appropriate management strategies, utilizing traditional testosterone replacement therapies and newer modalities such as transdermal patches, gels and buccal tablets;
- Monitor ongoing therapy more confidently to optimize outcomes and minimize morbidity.
AMA PRA Category 1 Credit(s)TM
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The National Association for Continuing Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Mohit Khera, MD, MBA, MPH
Assistant Professor of Urology
Division of Male Reproductive Medicine and Surgery
Scott Department of Urology
Baylor College of Medicine
Planning Committee:André T. Guay, MD, FACP, FACE
Assistant Clinical Professor of Medicine
Director, Center For Sexual Function
Lahey Clinic Northshore
Peabody, MALouis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida
Gainesville, FLMartin Miner, MD
Men’s Health Center
Chief of Family and Community Medicine
Clinical Associate Professor of Family Medicine
Warren Alpert School of Medicine
Brown University Gregg Sherman, MD
Margate Medical Associates
Accreditor Disclosure of Conflicts of Interest Policy:
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.
Faculty and Planning Committee Disclosures:
André T. Guay, MD, FACP, FACE serves on the advisory board for Auxilium, Bayer, Schering, P&G, Repros Pharmaceuticals, and Endo Pharmaceuticals and he speaks for Auxilium, Bayer, Schering, P&G, and Solvay.
Mohit Khera, MD, MBA speaks for Auxilium and receives research support from Allergan and Auxilium.
Louis Kuritzky, MD serves as consultant/on the advisory board for Boehringer-Ingelheim.
Martin Miner, MD serves as a consultant to Auxilium and Boehringer Ingelheim and he receives research support from GlaxoSmithKline.
Gregg Sherman, MD has no relationships to disclose.
The following NACE planners and managers have no relationships to disclose: Harvey Parker, PhD, CCMEP, Michelle Frisch, MPH, CCMEP, and Alan Goodstat, LCSW.
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. National Association for Continuing Education, Solvay Pharmaceuticals, Inc./Abbott, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of National Association for Continuing Education, Solvay Pharmaceuticals, Inc./Abbott, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity is sponsored by the National Association for Continuing Education.
If you have any questions relating to the accreditation of this activity, please contact email@example.com.
This program is supported by an educational grant from Solvay Pharmaceuticals, Inc., which was acquired by Abbott.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.